UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 26, 2003
APPLIED DNA SCIENCES , INC.
------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 2 90519 59-2262718
---------------------------- ----------- -------------------
(State or other jurisdiction Commission (IRS Employer
of Incorporation) File Number Identification No.)
9225 Sunset Boulevard Los Angeles, CA 90069
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (310) 860-1362
(Former name or former address, if changed since last report.)
Item 5. Other Information
On November 26, 2003, NASDAQ erroneously attached an "E" to Applied DNA
Sciences, Inc.'s Over the Counter Bulletin Board symbol of APDN, implying that
the Company was delinquent in its filings. All Applied DNA Sciences, Inc. SEC
reports have been timely filed. NASDAQ was notified immediately of its error,
and the E was removed the following market day, November 28, 2003.
The fiscal year end for Applied DNA Sciences, Inc. is September 30th, and its
next report to the Securities and Exchange Commission is its annual report,
which is due 90 days after the Company's year end. The current report disclosing
the Company's new fiscal year end was filed with the SEC in February of 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
APPLIED DNA SCIENCES, INC.
/s/ Lawrence C. Lee
------------------------------
Lawrence C. Lee
Chief Executive Officer